Patent details
LUC00026 Product Name: Irinotecan sucrosofate salt, such as irinotecan sucrosofate salt in a pegylated liposome, such as a liposome comprising 1,2-distearoyl-SN-phosphatidylcholine, cholesterol and N-(omega-methoxy-poly(ethylene glycol) (molecular weight 2000)-oxycarbonyl)-1,2-distearoylphosphatidyl ethanolamine, e.g. in the molar ratio 3:2:0.015
Basic Information
- Publication number:
- LUC00026
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP057455057
- Legal Status:
- Active
- Application number:
- LUC00026
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/16/1130
- Marketing Authorization Type:
- Marketing Authorization Date:
- 18/10/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 07/07/2017
- First Marketing Authorization date:
- 18/10/2016
- Grant date:
- 08/09/2017
- Activation date:
- 02/05/2025
- Publication date:
- 11/07/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 02/05/2030
- SPC Extension Expiration:
- 02/05/2030
- Rejection date:
- Withdrawal date:
Owner
- From:
- 27/09/2017
- Name:
- Ipsen Biopharm Ltd.
- Address:
- Ash Road, Wrexham Industrial Estate, Wrexham LL13 9UF, United Kingdom (GB)
History of Owners
- From:
- 07/07/2017
- To:
- 27/09/2017
- Name:
- Merrimack Pharmaceuticals Inc.
- Address:
- One Kendall Square Suite B7201, Cambridge, MA 02139, United States (US)
Agent
- Name:
- DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
- From:
- 07/07/2017
- Address:
- PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2017/04
- Publication date:
- 04/08/2017
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2017/06
- Publication date:
- 10/10/2017
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2017/06
- Publication date:
- 10/10/2017
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
4
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/07
- Publication date:
- 04/06/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20170000358A
- Date Registered:
- 27/09/2017
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Ipsen Biopharm Ltd.
- Address:
- Ash Road, Wrexham Industrial Estate, Wrexham LL13 9UF, United Kingdom (GB)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/05/2027
- Annual Fee Number:
- 23
- Annual Fee Amount:
- 430 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 29/04/2026
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 420 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 07/07/2017 | General Document | 18 |
| 11/07/2017 | Outgoing Correspondence | 1 |
| 07/07/2017 | General Document | 3 |
| 07/07/2017 | General Document | 1 |
| 27/09/2017 | Request For Change | 10 |
| 07/07/2017 | Application Form | 5 |
| 08/09/2017 | Certificate | 1 |
| 07/07/2017 | General Document | 40 |
| 11/07/2017 | Publication | 1 |
| 08/09/2017 | Publication | 1 |
| 07/07/2017 | General Document | 3 |
| 29/09/2017 | Outgoing Correspondence | 1 |
| 07/07/2017 | General Document | 2 |